$WINV
WinVest Acquisition Corp Stock $winv

$winv Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223010393 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$569.6K	$538.9K	$1.322M
YoY Change	126.21%	114.82%	316.22%
Operating Profit	-$569.6K		-$1.322M
YoY Change	126.21%
Interest Expense	$209.1K	$716.8K	$1.409M
YoY Change	1686.75%	29155.51%	53687.79%
% of Operating Profit
Other Income/Expense, Net	$209.1K		$1.409M
YoY Change	1687.37%
Pretax Income	-$360.5K	$177.9K	$87.37K
YoY Change	50.16%	-171.6%	-127.74%
Income Tax	$44.00K	$187.4K	$314.0K
% Of Pretax Income		105.36%	359.4%
Net Earnings	-$404.5K	-$9.550K	-$226.6K
YoY Change	68.48%	-96.16%	-28.05%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.14	$0.00	-$0.08
COMMON SHARES
Basic Shares Outstanding	4.768M shares	14.38M shares	1.898M shares
Diluted Shares Outstanding	2.875M shares		2.875M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$57.05K	$88.25K	$88.25K
YoY Change	-81.45%	-82.62%	-82.62%
Cash & Equivalents	$57.05K	$88.25K
Short-Term Investments
Other Short-Term Assets	$230.7K	$277.8K	$277.8K
YoY Change	-47.36%	-29.41%	-29.41%
Inventory
Prepaid Expenses	$230.7K	$277.8K
Receivables
Other Receivables
Total Short-Term Assets	$287.7K	$366.0K	$366.0K
YoY Change	-61.42%	-59.39%	-59.39%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$20.01M	$19.57M	$19.57M
YoY Change	-82.78%	-83.15%	-83.15%
Other Assets
YoY Change
Total Long-Term Assets	$20.01M	$19.57M	$19.57M
YoY Change	-82.8%	-83.19%	-83.19%
TOTAL ASSETS
Total Short-Term Assets	$287.7K	$366.0K	$366.0K
Total Long-Term Assets	$20.01M	$19.57M	$19.57M
Total Assets	$20.29M	$19.94M	$19.94M
YoY Change	-82.67%	-83.01%	-83.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$708.3K	$489.9K	$489.9K
YoY Change	2260.93%	416.96%	416.96%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$623.0K	$125.0K	$125.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.689M	$928.9K	$928.9K
YoY Change	1736.77%	880.24%	880.23%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$4.025M	$4.025M	$4.025M
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Liabilities	$4.025M	$4.025M	$4.025M
YoY Change	0.0%	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.689M	$928.9K	$928.9K
Total Long-Term Liabilities	$4.025M	$4.025M	$4.025M
Total Liabilities	$5.714M	$4.954M	$4.954M
YoY Change	38.8%	20.25%	20.25%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.427M	-$4.588M
YoY Change		56.1%
Common Stock	$288.00	$288.00
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.427M	-$4.588M	$14.98M
YoY Change
Total Liabilities & Shareholders Equity	$20.29M	$19.94M	$19.94M
YoY Change	-82.67%	-83.01%	-83.01%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$404.5K	-$9.550K	-$226.6K
YoY Change	68.48%	-96.16%	-28.05%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$304.1K	-$140.6K	-$534.2K
YoY Change	51.8%	47.48%	-40.18%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$225.2K	$97.89M	$97.99M
YoY Change			-184.37%
Cash From Investing Activities	-$225.1K	$97.89M	$97.99M
YoY Change			-184.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$498.0K	-97.88M	-$97.88M
YoY Change			-183.26%
NET CHANGE
Cash From Operating Activities	-$304.1K	-140.6K	-$534.2K
Cash From Investing Activities	-$225.1K	97.89M	$97.99M
Cash From Financing Activities	$498.0K	-97.88M	-$97.88M
Net Change In Cash	-$31.20K	-128.0K	-$419.7K
YoY Change		34.3%	-182.63%
FREE CASH FLOW
Cash From Operating Activities	-$304.1K	-$140.6K	-$534.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001854463
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent		usd
CY2021Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2022	WINV	Formation Costs Paid By Thirdparty FormationCostsPaidByThirdparty		usd
	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable		usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
	WINV	Proceeds From Trust Account To Redeeming Stockholders ProceedsFromTrustAccountToRedeemingStockholders		usd
	WINV	Proceeds From Withdrawal Of Interest From Trust Account To Pay Taxes ProceedsFromWithdrawalOfInterestFromTrustAccountToPayTaxes		usd
	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2022	WINV	Payment Of Offering Costs PaymentOfOfferingCosts		usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates		usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment		usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-40796
CY2022	dei	Entity Registrant Name EntityRegistrantName	WINVEST ACQUISITION CORP.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2451181
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	125 Cambridgepark Drive
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 301
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Cambridge
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02140
CY2022	dei	City Area Code CityAreaCode	(617)
CY2022	dei	Local Phone Number LocalPhoneNumber	658-3094
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022Q2	dei	Entity Public Float EntityPublicFloat	114310000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4768113	shares
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Marcum LLP
CY2022	dei	Auditor Location AuditorLocation	Houston, TX
CY2022Q4	us-gaap	Cash Cash	88247	usd
CY2021Q4	us-gaap	Cash Cash	507906	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	277776	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	393500	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	366023	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	901406	usd
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	276797	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	19571562	usd
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	116152616	usd
CY2022Q4	us-gaap	Assets Assets	19937585	usd
CY2021Q4	us-gaap	Assets Assets	117330819	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	382872	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	94760	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	314000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	107000	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	125000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	928872	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	94760	usd
CY2022Q4	WINV	Deferred Underwriting Commission Payable DeferredUnderwritingCommissionPayable	4025000	usd
CY2021Q4	WINV	Deferred Underwriting Commission Payable DeferredUnderwritingCommissionPayable	4025000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4953872	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4119760	usd
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1893113	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	11500000	shares
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.15
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5733920	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5733920	shares
CY2021Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.10
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	19571562	usd
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	116150000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2875000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2875000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2875000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2875000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1893113	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	288	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	288	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4588137	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2939229	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4587849	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2938941	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19937585	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	117330819	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1321875	usd
	us-gaap	Operating Expenses OperatingExpenses	317588	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1321875	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-317588	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	1409243	usd
	us-gaap	Interest Income Other InterestIncomeOther	2616	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1409243	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2616	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	87368	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-314972	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	314000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-226632	usd
	us-gaap	Net Income Loss NetIncomeLoss	-314972	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1898300	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3929508	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2875000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2875000	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
	WINV	Stock Issued During Period Value Capital Contribution For Transfer Of Founder Shares To Directors And Advisors StockIssuedDuringPeriodValueCapitalContributionForTransferOfFounderSharesToDirectorsAndAdvisors	-34	usd
	WINV	Stock Issued During Period Value Sale Of Shares To Directors And Advisors StockIssuedDuringPeriodValueSaleOfSharesToDirectorsAndAdvisors	34	usd
	WINV	Adjustments To Additional Paid In Capital Sale Of Private Placement Warrants AdjustmentsToAdditionalPaidInCapitalSaleOfPrivatePlacementWarrants	5450000	usd
	WINV	Adjustments To Additional Paid In Capital Deposit To Trust Account From Private Placement AdjustmentsToAdditionalPaidInCapitalDepositToTrustAccountFromPrivatePlacement	-1150000	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	2357500	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	136008	usd
	WINV	Adjustments To Additional Paid In Capital Warrant Issued Offering Costs Allocated To Private Placement AdjustmentsToAdditionalPaidInCapitalWarrantIssuedOfferingCostsAllocatedToPrivatePlacement	-314420	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	8856041	usd
	us-gaap	Net Income Loss NetIncomeLoss	-314972	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2938941	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2938941	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	1422276	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-226632	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4587849	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-226632	usd
	us-gaap	Net Income Loss NetIncomeLoss	-314972	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	1409243	usd
	us-gaap	Interest Income Other InterestIncomeOther	2616	usd
	WINV	Formation Costs Paid By Thirdparty FormationCostsPaidByThirdparty	337	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-392521	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	670297	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	288111	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	94423	usd
CY2022	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	314000	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	107000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-534243	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-893125	usd
CY2022	WINV	Proceeds From Trust Account To Redeeming Stockholders ProceedsFromTrustAccountToRedeemingStockholders	98000714	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	125000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	116150000	usd
CY2022	WINV	Proceeds From Withdrawal Of Interest From Trust Account To Pay Taxes ProceedsFromWithdrawalOfInterestFromTrustAccountToPayTaxes	114583	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	97990297	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-116150000	usd
CY2022	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	98000714	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	125000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	112600000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	5450000	usd
	WINV	Payment Of Offering Costs PaymentOfOfferingCosts	523969	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-97875714	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	117551031	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-419659	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	507906	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	507906	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	88247	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	507906	usd
CY2022	WINV	Accretion Of Common Stock Subject To Redemption AccretionOfCommonStockSubjectToRedemption	1422275	usd
	WINV	Accretion Of Common Stock Subject To Redemption AccretionOfCommonStockSubjectToRedemption	8856041	usd
CY2022	WINV	Non Cash Deferred Underwriting Commissions NonCashDeferredUnderwritingCommissions	4025000	usd
	WINV	Non Cash Deferred Underwriting Commissions NonCashDeferredUnderwritingCommissions	4025000	usd
CY2022	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	125000	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	10000000	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	100000000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	100000	usd
CY2022	WINV	Percentage Of Deferred Underwriting Discounts And Commissions Payable To Underwriters PercentageOfDeferredUnderwritingDiscountsAndCommissionsPayableToUnderwriters	0.035	pure
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zI8DKhv4rVKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zWnhbEQOelS6">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2021Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	116150000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zeP1JyzT2tB3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zqY5ire2Pf1i">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_902_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_zG53A6nAvbYd" title="Cash, FDIC insured amount">250,000</span>. As of December 31, 2022, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	19571562	usd
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	116152616	usd
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-181892	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1898300	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3929508	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022	WINV	Net Loss Applicable To Nonredeemable Common Shares Including Accretion Of Temporary Equity NetLossApplicableToNonredeemableCommonSharesIncludingAccretionOfTemporaryEquity	-226632	usd
	WINV	Net Loss Applicable To Nonredeemable Common Shares Including Accretion Of Temporary Equity NetLossApplicableToNonredeemableCommonSharesIncludingAccretionOfTemporaryEquity	-133080	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2875000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2875000	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022	WINV	Change In Value Of Common Stock Subject To Possible Redemption Shares ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares	11966667	shares
CY2022Q4	us-gaap	Cash Cash	88247	usd
CY2022	WINV	Working Capital WorkingCapital	248849	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-226632	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-534243	usd
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	2923969	usd
CY2022	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	2400000	usd
CY2022Q4	WINV	Deferred Underwriting Commissions DeferredUnderwritingCommissions	4025000	usd
CY2021Q4	us-gaap	Due From Related Parties DueFromRelatedParties	220317	usd
CY2022Q4	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	0.50
CY2022	us-gaap	Professional Fees ProfessionalFees	10000	usd
CY2022Q3	WINV	Percentage Of Aggregate Sales Price Of Securities Sold PercentageOfAggregateSalesPriceOfSecuritiesSold	0.05	pure
CY2022Q4	WINV	Deferred Underwriting Commissions DeferredUnderwritingCommissions	4025000	usd
CY2021Q4	WINV	Deferred Underwriting Commissions DeferredUnderwritingCommissions	4025000	usd
	WINV	Common Shares Subject Possible Redemption Gross Proceeds CommonSharesSubjectPossibleRedemptionGrossProceeds	115000000	usd
	WINV	Offering Costs Allocated To Common Stock Subject To Possible Redemption OfferingCostsAllocatedToCommonStockSubjectToPossibleRedemption	-6498541	usd
	WINV	Proceeds From Issuance Of Public Warrants ProceedsFromIssuanceOfPublicWarrants	2357500	usd
	WINV	Deposit To Trust Account From Private Placement DepositToTrustAccountFromPrivatePlacement	1150000	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	8856041	usd
CY2022Q1	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	116150000	usd
CY2022	WINV	Redemption Of Common Stock RedemptionOfCommonStock	98000714	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	19571562	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	11.50
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	241000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	73000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	314000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-222850	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-66144	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-67100	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-19906	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-289950	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-86050	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	289950	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	86050	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	314000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.063	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.063	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	3.318	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.273	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	3.591	pure
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16507	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	376000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	69543	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	376000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	86050	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	376000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	86050	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	376000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	86050	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	289950	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	86050	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
winv-20221231_cal.xml	Edgar Link	unprocessable
0001493152-23-010393-index-headers.html	Edgar Link	pending
0001493152-23-010393-index.html	Edgar Link	pending
0001493152-23-010393.txt	Edgar Link	pending
0001493152-23-010393-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
winv-20221231.xsd	Edgar Link	pending
winv-20221231_def.xml	Edgar Link	unprocessable
winv-20221231_lab.xml	Edgar Link	unprocessable
winv-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WINV
WinVest Acquisition Corp Stock $winv

2023 Q1 Form 10-K Financial Statement

#000149315223010393 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WINV WinVest Acquisition Corp Stock $winv

2023 Q1 Form 10-K Financial Statement

#000149315223010393 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WINV
WinVest Acquisition Corp Stock $winv